Cargando…

Quantitative Proteomic Profiling Identifies a Potential Novel Chaperone Marker in Resistant Breast Cancer

Development of aromatase inhibitor resistant breast cancer among postmenopausal women continues to be a major clinical obstacle. Previously, our group demonstrated that as breast cancer cells transition from hormone-dependent to hormone-independent, they are associated with increased growth factor s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallegos, Karen M., Patel, Jankiben R., Llopis, Shawn D., Walker, Rashidra R., Davidson, A. Michael, Zhang, Wensheng, Zhang, Kun, Tilghman, Syreeta L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951058/ https://www.ncbi.nlm.nih.gov/pubmed/33718123 http://dx.doi.org/10.3389/fonc.2021.540134

Ejemplares similares

A novel and cost-effective ex vivo orthotopic model for the study of human breast cancer in mouse mammary gland organ culture
por: Gupta, Akash, et al.
Publicado: (2020)

Glyceollins Trigger Anti-Proliferative Effects in Hormone-Dependent Aromatase-Inhibitor-Resistant Breast Cancer Cells through the Induction of Apoptosis
por: Walker, Rashidra R., et al.
Publicado: (2022)

Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1
por: Patel, Jankiben R., et al.
Publicado: (2023)

A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells
por: Patel, Jankiben R., et al.
Publicado: (2022)

Quantitative Proteomic Profiling Identifies SOX8 as Novel Regulator of Drug Resistance in Gestational Trophoblastic Neoplasia
por: Jun, Fu, et al.
Publicado: (2020)

Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer
por: Titmarsh, Helen F., et al.
Publicado: (2023)

Quantitative proteomic studies addressing unmet clinical needs in sarcoma
por: Connolly, Elizabeth A., et al.
Publicado: (2023)

Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients
por: Li, Mei-Yong, et al.
Publicado: (2021)

Protein Kinase CK2 Expression Predicts Relapse Survival in ERα Dependent Breast Cancer, and Modulates ERα Expression in Vitro
por: Williams, Marlon D., et al.
Publicado: (2015)

Quantitative Proteomic Analysis Identifies MAPK15 as a Potential Regulator of Radioresistance in Nasopharyngeal Carcinoma Cells
por: Li, Zhanzhan, et al.
Publicado: (2018)

Chaperone Mediated Autophagy Substrates and Components in Cancer
por: Rios, Javiera, et al.
Publicado: (2021)

An Integrated Quantitative Proteomics Workflow for Cancer Biomarker Discovery and Validation in Plasma
por: Kumar, Vipin, et al.
Publicado: (2020)

The Endoplasmic Reticulum Chaperone GRP170: From Immunobiology to Cancer Therapeutics
por: Wang, Hongxia, et al.
Publicado: (2015)

Proteomic profiling of cell line-derived extracellular vesicles to identify candidate circulatory markers for detection of gallbladder cancer
por: Priya, Ratna, et al.
Publicado: (2022)

Prognostic role of preoperative inflammatory markers in postoperative patients with colorectal cancer
por: Xiao, Zilong, et al.
Publicado: (2023)

Mechanisms of Translocation of ER Chaperones to the Cell Surface and Immunomodulatory Roles in Cancer and Autoimmunity
por: Wiersma, Valerie R., et al.
Publicado: (2015)

Endoplasmic Reticulum Chaperones and Their Roles in the Immunogenicity of Cancer Vaccines
por: Graner, Michael W., et al.
Publicado: (2015)

Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer
por: Flores-Morales, Amilcar, et al.
Publicado: (2017)

The Mitochondrial Chaperone TRAP1 as a Candidate Target of Oncotherapy
por: Xie, Shulan, et al.
Publicado: (2021)

Molecular Markers of MDR of Chemotherapy for HSCC: Proteomic Screening With High-Throughput Liquid Chromatography-Tandem Mass Spectrometry
por: Shen, Bin, et al.
Publicado: (2021)

Isobaric Tags for Relative and Absolute Quantitation in Proteomic Analysis of Potential Biomarkers in Invasive Cancer, Ductal Carcinoma In Situ, and Mammary Fibroadenoma
por: Wu, Hao, et al.
Publicado: (2020)

Quantitative Expression of Key Cancer Markers in the AS-30D Hepatocarcinoma Model
por: Briones-Orta, Marco A., et al.
Publicado: (2021)

The Chaperone TRAP1 As a Modulator of the Mitochondrial Adaptations in Cancer Cells
por: Masgras, Ionica, et al.
Publicado: (2017)

Dynamic Activity of Histone H3-Specific Chaperone Complexes in Oncogenesis
por: Wen, Ting, et al.
Publicado: (2022)

Quantitative Proteomic Analysis Reveals Important Roles of the Acetylation of ER-Resident Molecular Chaperones for Conidiation in Fusarium oxysporum
por: Lv, Fangjiao, et al.
Publicado: (2022)

PLA2G6 Silencing Suppresses Melanoma Progression and Affects Ferroptosis Revealed by Quantitative Proteomics
por: Wang, Yifei, et al.
Publicado: (2022)

A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma
por: Pandey, Kirti, et al.
Publicado: (2023)

Endoplasmic Reticulum Chaperones and Oxidoreductases: Critical Regulators of Tumor Cell Survival and Immunorecognition
por: Gutiérrez, Tomás, et al.
Publicado: (2014)

Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target
por: Duan, Xiaofeng, et al.
Publicado: (2021)

Comprehending Meningioma Signaling Cascades Using Multipronged Proteomics Approaches & Targeted Validation of Potential Markers
por: Mukherjee, Shuvolina, et al.
Publicado: (2020)

Identifying diagnostic markers and constructing a prognostic model for small-cell lung cancer based on blood exosome-related genes and machine-learning methods
por: Zhang, Kun, et al.
Publicado: (2022)

The use of quantitative T1-mapping to identify cells and collagen fibers in rectal cancer
por: Yuan, Jie, et al.
Publicado: (2023)

Insulin-Like Growth Factor-1 Signaling Regulates miRNA Expression in MCF-7 Breast Cancer Cell Line
por: Martin, Elizabeth C., et al.
Publicado: (2012)

HSP70 and HSP90 in Cancer: Cytosolic, Endoplasmic Reticulum and Mitochondrial Chaperones of Tumorigenesis
por: Albakova, Zarema, et al.
Publicado: (2022)

Proteomic Analyses Identify Therapeutic Targets in Hepatocellular Carcinoma
por: Elmas, Abdulkadir, et al.
Publicado: (2022)

Quantitative SWATH-Based Proteomic Profiling for Identification of Mechanism-Driven Diagnostic Biomarkers Conferring in the Progression of Metastatic Prostate Cancer
por: Singh, Anshika N., et al.
Publicado: (2020)

Quantitative tissue proteome profile reveals neutrophil degranulation and remodeling of extracellular matrix proteins in early stage gallbladder cancer
por: Akhtar, Javed, et al.
Publicado: (2023)

Corrigendum: HSP70 and HSP90 in cancer: cytosolic, endoplasmic reticulum and mitochondrial chaperones of tumorigenesis
por: Albakova, Zarema, et al.
Publicado: (2023)

Proteomics Analysis Identified ASNS as a Novel Biomarker for Predicting Recurrence of Skull Base Chordoma
por: Shen, Yutao, et al.
Publicado: (2021)

Quantitative analysis of serum cell-free DNA as a predictive and prognostic marker in breast cancer patients
por: Sultana, Gazi Nurun Nahar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j916aa8rhpapvo6m9fmdtnc242